# Western Alliance Bancorporation: financial statements, quarterly

WAL · NYSE · CIK 1212545 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wal.md) · [Financials](/companies/wal/financials.md) · [Filings](/companies/wal/filings.md) · [Insiders](/companies/wal/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wal/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.6](/filings/0001212545-24-000293.md) | [30.7 d](/filings/0001628280-26-010336.md) | [13.5](/filings/0001212545-25-000141.md) | [16.9](/filings/0001212545-25-000214.md) | [15.2](/filings/0001628280-25-047883.md) | [22.1 d](/filings/0001628280-26-010336.md) | [23.0](/filings/0001628280-26-033054.md) | [23.5](/filings/0001628280-26-051418.md) | [24.5](/filings/0001628280-25-047883.md) | [64.8 d](/filings/0001628280-26-010336.md) | [67.2](/filings/0001628280-26-033054.md) | [45.7](/filings/0001628280-26-051418.md) |
| Interest expense | $m | [440](/filings/0001212545-23-000163.md) | [447 d](/filings/0001212545-24-000092.md) | [456](/filings/0001212545-24-000145.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [61.3](/filings/0001212545-24-000293.md) | [63.1 d](/filings/0001628280-26-010336.md) | [54.4](/filings/0001212545-25-000141.md) | [54.3](/filings/0001212545-25-000214.md) | [52.3](/filings/0001628280-25-047883.md) | [42.5 d](/filings/0001628280-26-010336.md) | [47.3](/filings/0001628280-26-033054.md) | [53.5](/filings/0001628280-26-051418.md) | [53.3](/filings/0001628280-25-047883.md) | [62.5 d](/filings/0001628280-26-010336.md) | [42.1](/filings/0001628280-26-033054.md) | [63.2](/filings/0001628280-26-051418.md) |
| Net income | $m | [217](/filings/0001212545-24-000293.md) | [148 d](/filings/0001628280-26-010336.md) | [177](/filings/0001212545-25-000141.md) | [194](/filings/0001212545-25-000214.md) | [200](/filings/0001628280-25-047883.md) | [217 d](/filings/0001628280-26-010336.md) | [199](/filings/0001628280-26-033054.md) | [230](/filings/0001628280-26-051418.md) | [253](/filings/0001628280-25-047883.md) | [286 d](/filings/0001628280-26-010336.md) | [182](/filings/0001628280-26-033054.md) | [262](/filings/0001628280-26-051418.md) |
| Diluted EPS | $ per share | [1.97](/filings/0001212545-24-000293.md) | not reported | [1.60](/filings/0001212545-25-000141.md) | [1.75](/filings/0001212545-25-000214.md) | [1.80](/filings/0001628280-25-047883.md) | not reported | [1.79](/filings/0001628280-26-033054.md) | [2.07](/filings/0001628280-26-051418.md) | [2.28](/filings/0001628280-25-047883.md) | not reported | [1.65](/filings/0001628280-26-033054.md) | [2.36](/filings/0001628280-26-051418.md) |
| Basic EPS | $ per share | [1.97](/filings/0001212545-24-000293.md) | not reported | [1.61](/filings/0001212545-25-000141.md) | [1.75](/filings/0001212545-25-000214.md) | [1.81](/filings/0001628280-25-047883.md) | not reported | [1.80](/filings/0001628280-26-033054.md) | [2.08](/filings/0001628280-26-051418.md) | [2.30](/filings/0001628280-25-047883.md) | not reported | [1.65](/filings/0001628280-26-033054.md) | [2.37](/filings/0001628280-26-051418.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [70.9](/filings/0001212545-23-000163.md) | [70.9](/filings/0001212545-25-000090.md) | [77.0](/filings/0001212545-24-000145.md) | [80.6](/filings/0001212545-24-000224.md) | [80.1](/filings/0001212545-24-000293.md) | [80.9](/filings/0001628280-26-010336.md) | [83.0](/filings/0001212545-25-000141.md) | [86.7](/filings/0001212545-25-000214.md) | [91.0](/filings/0001628280-25-047883.md) | [92.8](/filings/0001628280-26-051418.md) | [98.9](/filings/0001628280-26-033054.md) | [98.7](/filings/0001628280-26-051418.md) |
| Total liabilities | $bn | [65.1](/filings/0001212545-23-000163.md) | [64.8](/filings/0001212545-25-000090.md) | [70.8](/filings/0001212545-24-000145.md) | [74.2](/filings/0001212545-24-000224.md) | [73.4](/filings/0001212545-24-000293.md) | [74.2](/filings/0001628280-26-010336.md) | [75.8](/filings/0001212545-25-000141.md) | [79.3](/filings/0001212545-25-000214.md) | [83.3](/filings/0001628280-25-047883.md) | [84.8](/filings/0001628280-26-051418.md) | [90.9](/filings/0001628280-26-033054.md) | [90.6](/filings/0001628280-26-051418.md) |
| Long-term debt | $bn | [0.8](/filings/0001212545-23-000163.md) | [0.4](/filings/0001212545-25-000090.md) | [0.4](/filings/0001212545-24-000145.md) | [0.4](/filings/0001212545-24-000224.md) | [1.4](/filings/0001212545-24-000293.md) | [2.4](/filings/0001628280-26-010336.md) | [1.6](/filings/0001212545-25-000141.md) | [2.9](/filings/0001212545-25-000214.md) | [2.9](/filings/0001628280-25-047883.md) | [1.4](/filings/0001628280-26-051418.md) | [1.1](/filings/0001628280-26-033054.md) | [1.5](/filings/0001628280-26-051418.md) |
| Short-term borrowings | $bn | [8.0](/filings/0001212545-23-000163.md) | [6.8](/filings/0001212545-25-000090.md) | [5.8](/filings/0001212545-24-000145.md) | [5.2](/filings/0001212545-24-000224.md) | [1.6](/filings/0001212545-24-000293.md) | [3.2](/filings/0001628280-26-010336.md) | [2.5](/filings/0001212545-25-000141.md) | [3.1](/filings/0001212545-25-000214.md) | [1.0](/filings/0001628280-25-047883.md) | [3.8](/filings/0001628280-26-051418.md) | [4.5](/filings/0001628280-26-033054.md) | [4.8](/filings/0001628280-26-051418.md) |
| Shareholders' equity | $bn | [5.7](/filings/0001212545-24-000293.md) | [6.1](/filings/0001212545-25-000090.md) | [6.2](/filings/0001212545-24-000224.md) | [6.3](/filings/0001212545-24-000293.md) | [6.7](/filings/0001212545-24-000293.md) | [6.7](/filings/0001628280-26-010336.md) | [6.9](/filings/0001212545-25-000141.md) | [7.1](/filings/0001212545-25-000214.md) | [7.4](/filings/0001628280-25-047883.md) | [7.7](/filings/0001628280-26-051418.md) | [7.6](/filings/0001628280-26-033054.md) | [7.8](/filings/0001628280-26-051418.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(570) d](/filings/0001212545-24-000293.md) | [341 d](/filings/0001628280-26-010336.md) | [(307)](/filings/0001212545-25-000141.md) | [(746) d](/filings/0001212545-25-000214.md) | [(1,068) d](/filings/0001628280-25-047883.md) | [(622) d](/filings/0001628280-26-010336.md) | [(1,654)](/filings/0001628280-26-033054.md) | [(358) d](/filings/0001628280-26-051418.md) | [(597) d](/filings/0001628280-25-047883.md) | [(69.8) d](/filings/0001628280-26-010336.md) | [(507)](/filings/0001628280-26-033054.md) | [(356) d](/filings/0001628280-26-051418.md) |
| Dividends paid | $m | [42.6 d](/filings/0001212545-24-000293.md) | [43.7 d](/filings/0001212545-25-000090.md) | [43.9](/filings/0001212545-25-000141.md) | [44.0 d](/filings/0001212545-24-000224.md) | [43.9 d](/filings/0001212545-24-000293.md) | [45.0 d](/filings/0001212545-25-000090.md) | [45.0](/filings/0001212545-25-000141.md) | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-26-010336.md) | [0.0](/filings/0001628280-26-033054.md) | [0.0 d](/filings/0001628280-26-051418.md) | [10.6 d](/filings/0001628280-25-047883.md) | [57.5 d](/filings/0001628280-26-010336.md) | [50.3](/filings/0001628280-26-033054.md) | [2.3 d](/filings/0001628280-26-051418.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [108](/filings/0001212545-23-000163.md) | [108](/filings/0001212545-24-000145.md) | [108](/filings/0001212545-24-000224.md) | [109](/filings/0001212545-24-000293.md) | [109](/filings/0001212545-25-000141.md) | [109](/filings/0001212545-25-000214.md) | [110](/filings/0001628280-25-047883.md) | [110](/filings/0001628280-26-033054.md) | [110](/filings/0001628280-26-051418.md) | [110](/filings/0001628280-25-047883.md) | [109](/filings/0001628280-26-033054.md) | [108](/filings/0001628280-26-051418.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 109,100,864 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051418.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.